Full name
"PHARMACEUTICAL RESEARCH ASSOCIATES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"PHARMACEUTICAL RESEARCH ASSOCIATES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. PROSTA 68, 00-838 WARSZAWA
TAX ID1130108877
Rate company:
"PHARMACEUTICAL RESEARCH ASSOCIATES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1130108877
KRS0000139607
Share capital50,000.00 zł
address
UL. PROSTA 68, 00-838 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1130108877
REGON
011121258
KRS
0000139607
Legal form
limited liability company
Register Address
UL. PROSTA 68, 00-838 WARSZAWA
Date of registration in KRS
2002-11-20
Date of commencement of economic activity
2002-11-20
Act signature
WA.XII NS-REJ.KRS/61522/23/73/ADE
Pkd codes
72.19.Z - Scientific research and development activities
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL68 1030 1508 0000 0008 2266 7000 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 4,2 | 5 | 7,6 | 53,5 |
EBITDA | 5,8 | 7,1 | 8,6 | 20,9 |
Short time liabilities | 4,9 | 4,2 | 5,8 | 39 |
Equity capital | 30,6 | 33,7 | 39,5 | 17,1 |
Operating profit (EBIT) | 5,4 | 6,6 | 8,1 | 22 |
Assets | 39,2 | 44,1 | 53,1 | 20,4 |
Net profit (loss) | 3,1 | 3,8 | 5,8 | 52,3 |
Cash | 3,4 | 4 | 3 | -25,7 |
Net income from sale | 134,2 | 159,8 | 166,3 | 4,1 |
Liabilities and provisions for liabilities | 8,5 | 10,4 | 13,6 | 31 |
Working assets | 37,1 | 41,7 | 49,9 | 19,7 |
Depreciation | 0,4 | 0,5 | 0,5 | 5,5 |
% | % | % | p.p. | |
Profitability of capital | 10,2 | 11,2 | 14,6 | 3,4 |
Equity capital to total assets | 78,2 | 76,4 | 74,4 | -2 |
Gross profit margin | 3,1 | 3,1 | 4,6 | 1,5 |
EBITDA Margin | 4,3 | 4,4 | 5,2 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 13 | 10 | 13 | 3 |
Current financial liquidity indicator | 4.39652156829834 | 4.772995471954346 | 4.600005149841309 | -0,2 |
Net dept to EBITDA | -0.5937150716781616 | -0.5668447613716125 | -0.3484211564064026 | 0,3 |
Financial statements
01-01-2022 - 31-12-2022
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Activity report
Download pdf01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.